MX2011009844A - Composicion farmaceutica que comprende alisquireno. - Google Patents
Composicion farmaceutica que comprende alisquireno.Info
- Publication number
- MX2011009844A MX2011009844A MX2011009844A MX2011009844A MX2011009844A MX 2011009844 A MX2011009844 A MX 2011009844A MX 2011009844 A MX2011009844 A MX 2011009844A MX 2011009844 A MX2011009844 A MX 2011009844A MX 2011009844 A MX2011009844 A MX 2011009844A
- Authority
- MX
- Mexico
- Prior art keywords
- aliskiren
- pharmaceutical composition
- filler
- pharmaceutically acceptable
- acceptable salt
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente invención se refiere a una composición farmacéutica, la cual comprende: a) una cantidad terapéuticamente efectiva de Alisquireno, o una sal farmacéuticamente aceptable del mismo, b) un relleno; y c) un relleno específico adicional.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16188309P | 2009-03-20 | 2009-03-20 | |
PCT/US2010/027748 WO2010107966A1 (en) | 2009-03-20 | 2010-03-18 | Pharmaceutical composition comprising aliskiren |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2011009844A true MX2011009844A (es) | 2011-09-29 |
Family
ID=42245650
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2011009844A MX2011009844A (es) | 2009-03-20 | 2010-03-18 | Composicion farmaceutica que comprende alisquireno. |
Country Status (12)
Country | Link |
---|---|
US (1) | US20120003308A1 (es) |
EP (1) | EP2408433A1 (es) |
JP (1) | JP2012520892A (es) |
KR (1) | KR20110129482A (es) |
CN (1) | CN102361633A (es) |
AR (1) | AR075881A1 (es) |
AU (1) | AU2010226615A1 (es) |
BR (1) | BRPI1009131A2 (es) |
CA (1) | CA2753221A1 (es) |
MX (1) | MX2011009844A (es) |
TW (1) | TW201038299A (es) |
WO (1) | WO2010107966A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2012520895A (ja) * | 2009-03-20 | 2012-09-10 | ノバルティス アーゲー | バルサルタンおよびアリスキレンの一定用量の組合せのガレヌス製剤 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY119161A (en) | 1994-04-18 | 2005-04-30 | Novartis Ag | Delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides with enzyme especially renin inhibiting activities |
AR048431A1 (es) * | 2004-03-17 | 2006-04-26 | Novartis Ag | Formulaciones galenicas de compuestos organicos |
MY146830A (en) * | 2005-02-11 | 2012-09-28 | Novartis Ag | Combination of organic compounds |
US20100209480A1 (en) * | 2007-09-28 | 2010-08-19 | Ralf Altenburger | Galenical formulations of organic compounds |
-
2010
- 2010-03-18 AR ARP100100866A patent/AR075881A1/es unknown
- 2010-03-18 MX MX2011009844A patent/MX2011009844A/es not_active Application Discontinuation
- 2010-03-18 US US13/256,462 patent/US20120003308A1/en not_active Abandoned
- 2010-03-18 EP EP10711496A patent/EP2408433A1/en not_active Withdrawn
- 2010-03-18 WO PCT/US2010/027748 patent/WO2010107966A1/en active Application Filing
- 2010-03-18 BR BRPI1009131A patent/BRPI1009131A2/pt not_active Application Discontinuation
- 2010-03-18 CA CA2753221A patent/CA2753221A1/en not_active Abandoned
- 2010-03-18 JP JP2012500947A patent/JP2012520892A/ja active Pending
- 2010-03-18 CN CN2010800126194A patent/CN102361633A/zh active Pending
- 2010-03-18 AU AU2010226615A patent/AU2010226615A1/en not_active Abandoned
- 2010-03-18 KR KR1020117024605A patent/KR20110129482A/ko not_active Application Discontinuation
- 2010-03-19 TW TW099108210A patent/TW201038299A/zh unknown
Also Published As
Publication number | Publication date |
---|---|
KR20110129482A (ko) | 2011-12-01 |
CN102361633A (zh) | 2012-02-22 |
BRPI1009131A2 (pt) | 2016-03-01 |
AR075881A1 (es) | 2011-05-04 |
US20120003308A1 (en) | 2012-01-05 |
TW201038299A (en) | 2010-11-01 |
AU2010226615A1 (en) | 2011-09-15 |
WO2010107966A1 (en) | 2010-09-23 |
JP2012520892A (ja) | 2012-09-10 |
CA2753221A1 (en) | 2010-09-23 |
EP2408433A1 (en) | 2012-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JOP20180102B1 (ar) | مركب صيدلاني | |
IN2012DN02805A (es) | ||
MX338712B (es) | Composicion farmaceutica que comprende linagliptina y opcionalmente un inhibidor de sglt2, y usos de la misma. | |
MY160456A (en) | Benzodiazepine bromodomain inhibitor | |
TN2014000030A1 (en) | Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds and use thereof as c5a receptor modulators | |
MY170935A (en) | Neprilysin inhibitors | |
MX2012007375A (es) | 3-ceto-n-propargil 1-aminoindano. | |
SG191175A1 (en) | Neprilysin inhibitors | |
MX2013001677A (es) | Formulaciones estables de linaclotida. | |
MX2013000642A (es) | Composiciones farmaceuticas. | |
MY187718A (en) | Pharmaceutical formulations | |
MX343689B (es) | Formulaciones combinadas de darunavir. | |
WO2011014825A3 (en) | Antiangiogenic small molecules and methods of use | |
UA93709C2 (ru) | 12-имидазолил-1-додеканол и его применение b изготовлении фармацевтических композиций | |
MX344473B (es) | Composicion farmaceutica acuosa semisolida que contiene tapentadol. | |
MX341976B (es) | Formulaciones de darunavir. | |
MX2014013851A (es) | Composiciones farmaceuticas topicas que comprenden terbinafina y urea. | |
TN2012000488A1 (en) | Pharmaceutical compositions comprising hydromorphone and naloxone | |
MY168212A (en) | A new therapeutical composition containing apomorphine as active ingredient | |
WO2008129501A3 (en) | Pharmaceutical compositions of duloxetine | |
SI2081904T1 (sl) | Aripiprazol hemifumarat in postopek za njegovo pripravo | |
EP2611799A4 (en) | PHARMACEUTICAL COMPOSITIONS OF LINEZOLID | |
MX349563B (es) | Formulacion farmaceutica de fenofibrato nanonizado. | |
EA201190282A1 (ru) | Фармацевтическая композиция, содержащая тамсулозин | |
EP2568810A4 (en) | COMPOSITIONS OF DARUNAVIR |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |